-
Mashup Score: 2Blood Podcast | Blood | American Society of Hematology - 2 hour(s) ago
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly in conjunction with each issue of Blood. Each episode will highlight selected content from recent articles published in Blood. Subscribe today to receive notification of each new episode as it’s published. Subscribe via…
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 6Volume 145 Issue 4 | Blood | American Society of Hematology - 5 hour(s) ago
Blood | 145 | 4 | January 2025
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 42024 Blood Journal Contest - 1 day(s) ago
9th Annual Blood Cover Art Contest is now open. In recognition of authors who published in Blood and images used in advancement of science, we invite you to vote for your favorite Blood cover from 2024. Only Blood cover art images from January 2024 – December 2024 were considered for this contest. The contest winner will be determined by the readers. The contest winner will be announced on February 13, 2025. This contest celebrates the extraordinary visual impact of the Blood cover art images and the authors who created them. Blood is not promoting any specific article, author, institution, or scientific field. The voting for this contest is based on visual impact only, not scientific or technical merit. See all the eligible covers by scrolling through the collection. To successfully vote, you will need to provide your email address. After you have voted, you will receive an email from (Easypromos) requesting you confirm your vote. If you do not confirm, your vote will not be counted.
Source: a.cstmapp.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 37Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study - 1 day(s) ago
Key PointsD-R maintenance improved MRD-negative conversion rate in patients with NDMM who were MRD-positive after transplant vs R maintenance.PFS favored D
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 22Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma - 1 day(s) ago
Key PointsWith a median follow-up of 24.2 months, the 2-year progression-free survival of patients treated with AN+AD was 88%.AN+AD led to an 88% CR rate a
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 142024 Blood Journal Contest - 2 day(s) ago
9th Annual Blood Cover Art Contest is now open. In recognition of authors who published in Blood and images used in advancement of science, we invite you to vote for your favorite Blood cover from 2024. Only Blood cover art images from January 2024 – December 2024 were considered for this contest. The contest winner will be determined by the readers. The contest winner will be announced on February 13, 2025. This contest celebrates the extraordinary visual impact of the Blood cover art images and the authors who created them. Blood is not promoting any specific article, author, institution, or scientific field. The voting for this contest is based on visual impact only, not scientific or technical merit. See all the eligible covers by scrolling through the collection. To successfully vote, you will need to provide your email address. After you have voted, you will receive an email from (Easypromos) requesting you confirm your vote. If you do not confirm, your vote will not be counted.
Source: a.cstmapp.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 13
Key PointsGenetic alteration of class I HLA genes is common in advanced cutaneous T-cell lymphoma but rarely affects total class I HLA expression.Genetic e
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 50Daratumumab for maintenance in myeloma - 2 day(s) ago
In this issue of Blood, Badros and colleagues present the results from AURIGA, the first phase 3 randomized trial comparing daratumumab lenalidomide (DR) t
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 23Is it time to screen for multiple myeloma? - 2 day(s) ago
In this issue, Visram et al1 make a significant advancement in the controversy of screening of multiple myeloma (MM) by providing an initial answer to the
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 60
BCR::ABL1-negative myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, prefibrotic myelofibrosis, and primary myel
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
🔊Season 9 Episode 4 out now! Targeting C3 in autoimmune hemolytic anemias; venetoclax testing to predict AML response; an improved understanding of the structure of FXIII complex 🎧https://t.co/Yus0Dp46x0 https://t.co/tsFDWV3jo0